Coordinated expression of activated mitogen-activated protein kinases in salivary gland adenoid cystic carcinoma

Adriana Handra-Luca1, Audrey Mauguen, Philippe Ménard

  • 1Service d'Anatomie Pathologique, APHP Hôpital Jean Verdier/GHU Paris 13/Nord, UPRES-EA 3406, Bondy, France. adriana.handra-luca@jvr.aphp.fr

Human Pathology
|July 29, 2008
PubMed

Insights

Mitogen-activated protein kinases are activated in adenoid cystic carcinoma, with coordinated signaling. High phosphorylated P38 levels predict patient survival, independent of tumor proliferation.

Area of Science:

  • Oncology
  • Molecular Biology
  • Pathology

Background:

  • The activation state of mitogen-activated protein kinases (MAPK) in salivary gland adenoid cystic carcinoma (ACC) is largely unknown.
  • Understanding MAPK activation is crucial for identifying potential therapeutic targets and prognostic markers in ACC.

Purpose of the Study:

  • To investigate the expression and activation status of key MAPK pathways (ERK, JNK, p38) in treatment-naive ACC.
  • To determine the correlation between MAPK activation, tumor cell proliferation (Ki67), and clinical outcomes, including perineural invasion and overall survival.

Main Methods:

  • Immunohistochemistry was employed to evaluate the expression of phosphorylated (activated) forms of ERK, JNK, and p38 kinases, alongside the Ki67 proliferation index.
  • A cohort of 61 treatment-naive ACC patients' archival paraffin-embedded tissues was analyzed using semiquantitative scoring.
  • Statistical analyses, including correlation assessments and Cox regression modeling, were performed to link molecular findings with clinical data.

Main Results:

  • Tumors exhibited heterogeneous expression patterns of phosphorylated MAPKs, with significant correlations observed between different MAPK activation states.
  • Phosphorylated JNK levels were associated with perineural invasion, a common feature of ACC.
  • High levels of phosphorylated p38 were found to be an independent predictor of improved overall survival in patients treated with surgery, while high Ki67 indicated poorer survival.

Conclusions:

  • MAPK pathways are indeed activated in ACC, and their activation appears to be coordinated.
  • Phosphorylated p38 kinase activation is a significant independent prognostic biomarker for overall survival in ACC patients.
  • These findings highlight the potential role of MAPK signaling in ACC pathogenesis and suggest therapeutic avenues targeting these pathways.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
MAPK Signaling Cascades01:07

MAPK Signaling Cascades

Mitogen-activated protein kinase, or MAPK pathway, activates three sequential kinases to regulate cellular responses such as proliferation, differentiation, survival, and apoptosis. The canonical MAPK pathway starts with a mitogen or growth factor binding to an RTK. The activated RTKs stimulate Ras, which recruits Raf or MAP3 Kinase (MAPKKK), the first kinase of the MAPK signaling cascade. Raf further phosphorylates and activates MEK or MAP2 Kinases (MAPKK), which in turn phosphorylates MAP...
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a rapamycin-insensitive companion...
Immunoglobulin-like Cell Adhesion Molecules01:31

Immunoglobulin-like Cell Adhesion Molecules

Immunoglobulin-like cell adhesion molecules or Ig-CAMs are a versatile group of cell surface glycoproteins belonging to the immunoglobulin protein superfamily. Ig-CAMs possess the characteristic immunoglobulin protein domains and other domains such as the fibronectin type III domain. The Ig domains are glycosylated to varying degrees in different Ig-CAMs.
Ig-CAMs exhibit either homophilic binding (to other Ig-CAMs) or heterophilic binding (to other ligands such as integrins). While most Ig-CAMs...